In general, the factors considered prior to initiating anakinra included the likelihood of IL-1 mediated inflammation, the child’s age, the severity of symptoms, the impact of the disease on growth and development, access to care in case of infection, previous treatment regimens, and medication compliance. Here, IL1B is linked to infection.